Nuvama Wealth Management has received final Sebi approval to enter the mutual fund business through Nuvama Asset Management. The company pl...

Public sector units like PFC, REC, and NaBFID are poised to increase their External Commercial Borrowings (ECBs) to leverage the RBI's 1.5%...

India's equity markets are poised for a busy period with over $6.3 billion in offerings expected in two months. This surge follows a subdue...

Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...

A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...

Ashish Dave, formerly of Mirae Asset Venture Investments, is launching Sanskrit Capital. The new fund aims for Rs 700-1,000 crore. It will ...

ICICI Prudential AMC CIO S Naren warned that rising leverage through derivatives and margin trading poses a bigger risk than any slowdown i...

Hong Kong-based Viridian Asia Opportunities Master Fund acquired an 18.96 lakh share stake in Lenskart Solutions for Rs 96 crore. This foll...

Britain is investing over a billion pounds to boost its AI computing power. A new national supercomputer is planned for 2030. The country i...

Subahoo Chordia, a key figure at Edelweiss Alternatives, has departed to launch his own infrastructure fund. He was instrumental in buildin...

Zerodha Mutual Fund has introduced two new life cycle funds, targeting investors for specific retirement years: 2041 and 2036. These open-e...

Three major asset management companies have imposed purchase restrictions on large investors in gold mutual fund schemes. This move aims to...

The RBI maintained its repo rate at 5.25% and a neutral stance, raising inflation forecasts due to West Asian conflict-driven oil price hik...

Last week, the Union Cabinet approved a Rs 10,000-crore price stabilisation fund for aviation turbine fuel, fixing a static price of Rs 115...

Shares of Alkem Laboratories will be in focus after block deals worth around Rs 930 crore saw 17.88 lakh shares traded at Rs 5,200 apiece o...

Alkem Laboratories shares experienced significant block deals totaling Rs 930 crore. Promoter family entities divested shares to a group of...

Global markets face uncertainty. Rajeev Agrawal from DoorDarshi India Fund sees India's economy as resilient. He focuses on domestic busine...